Regulatory overview of traditional medicines

Understand the requirements to import, manufacture or sell traditional medicines in Singapore.

What is a traditional medicine

In the local context, traditional medicines (TM) refer to Malay and Indian traditional medicinal products. They are finished products containing ingredients with uses documented in relevant TM references.

Food and supplements of food nature come under the purview of the Singapore Food Agency (SFA). View the interactive Food-Health Product Classification Tree1517 KB for more information.

Want to know more about CHP product classification? Click here for our FAQ.

Controls on traditional medicines

Traditional medicines are not subject to approvals and licensing by HSA for their importation, manufacture and sale. HSA prohibits the addition of medicinal ingredients such as steroids in TM. HSA also sets strict limits on toxic heavy metals in these products. Dealers (importers, manufacturers, wholesale dealers and sellers) have the obligation to ensure that their products are not harmful or unsafe, and that they conform with the following guidelines before supplying traditional medicines into Singapore.

Voluntary notification of traditional medicines

Dealers may voluntarily notify HSA of their traditional medicines supplied in Singapore. Companies must provide HSA with the relevant documents to demonstrate that their products meet the necessary safety and quality standards. Click here for more information.

Safety and quality standards

As a dealer of traditional medicines, you must ensure your products conform with our safety and quality standards.

Substances not allowed

Substances not allowed

Traditional medicines that are imported or sold must not contain the following:

  • Synthetic drugs.
  • Ingredients controlled and prohibited under the Poisons Act (Chapter 234) and Poisons Rules, Misuse of Drugs Act (Chapter 185) and its Regulations, and the ASEAN Guiding Principles for Inclusion into or Exclusion from the Negative List of Substances for Traditional Medicines at the ASEAN website (click on "POLICY & GUIDELINES" under "Key Documents & Publications" to expand the section and refer to point 11).
  • Ingredients derived from human parts.
  • Ingredients that may affect the human health (see Guidelines for Establishing Safety of Ingredients269 KB for more information).
  • Ingredients that contain agents that can lead to animal-transmissible diseases such as Transmissible Spongiform Encephalopathy (TSE). The guidelines on minimising the risk of TSE are available at: TSE guidelines236 KB
  • Ingredients regulated under the Endangered Species (Import & Export) Act, unless permitted. Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) import permit is needed from NParks.
  • Active substances that are not stated on the label.

    Toxic heavy metal limits

    Toxic heavy metal limits

    Your product must not exceed the following heavy metal limits:

    Heavy metal Permissible limits
    Arsenic 5 parts per million (ppm)
    Cadmium 0.3ppm
    Lead 10ppm
    Mercury 0.5ppm

    Microbial limits

    Microbial limits

    Your product must not exceed the following microbial limits:

    Oral products 

    Microbe  Microbial limits 

    Total aerobic microbial count

    Not more than 105 CFU per g or ml 

    Yeast and mould count

    Not more than 5 x 102 CFU per g or ml

    Escherichia coli, Salmonellae and Staphylococcus aureus

    Absent in 1g or ml

    Topical products 

    Microbe Microbial limits 
    Total aerobic microbial count Not more than 104 CFU per g or ml
    Yeast and mould count Not more than 5 x 10CFU per g or ml
    Pseudomonas aeruginosa and Staphyloccocus aureus Absent in 1g or ml

     

    Notwithstanding the limits stated above, it is the obligation of the dealers and sellers to ensure that the microbial content and heavy metals of the product is appropriate and safe when used according to the recommended conditions of use and target users. Dealers are encouraged to comply to the ASEAN Guidelines on the Limits of Contaminants for microbial limits. The applicable guidelines is posted at the ASEAN website (click on "POLICY & GUIDELINES" under "Key Documents & Publications" to expand the section and refer to point 11).

    Diethylene glycol and ethylene glycol limits

    Diethylene glycol and ethylene glycol limits

    Oral liquid CHPs must not exceed the following diethylene glycol and ethylene glycol limits:

    SubstanceQuantity (by weight)
    Diethylene glycol1000 parts per million (ppm)
    Ethylene glycol1000 ppm


    Quality standards

    Quality standards

    Your product needs to achieve acceptable standards of quality in terms of:

    • Product stability and shelf life   
    • Storage conditions and distribution practices
    • Manufacturing, packaging and assembly conditions

    Please refer to the following guidelines for more information: 

    Labelling standards

    Your product label should be prominent and conspicuous. Its information in English should be adequate and truthful. The label should contain the following:

    • Product Name (including Brand Name, if any)
    • Dosage Form
    • Name and Quantity of Active Ingredients
    • Product Indications / Intended Purpose
    • Dosage and Directions of Use
    • Batch Number
    • Expiry Date 
    • Country of Manufacture
    • Name and Address of Local Importer (for overseas manufactured product) or Product Owner (for locally manufactured product)
    • Contraindications, if any
    • Other Warnings, if any
    • Storage Condition
    • Pack Size / Net Content

    Please refer to the labelling standards guidelines288 KB for more information.

    Traditional medicines claims

    Please note that you are also not allowed to claim or indirectly suggest that the product will prevent, alleviate or cure any of the following conditions:

    1. Blindness
    2. Cancer
    3. Cataract
    4. Drug addiction
    5. Deafness
    6. Diabetes
    7. Epilepsy or fits
    8. Hypertension
    9. Insanity
    10. Kidney diseases
    11. Leprosy
    12. Menstrual disorder
    13. Paralysis
    14. Tuberculosis
    15. Sexual function
    16. Infertility
    17. Impotency
    18. Frigidity
    19. Conception and pregnancy

    Dealers must ensure that all health claims and information associated with the products are sufficiently supported and submitted to HSA as and when required. Otherwise, all unsubstantiated health claims and information will be considered misleading and must be removed from the product materials. Please refer to the Guidelines for Claims and Claim substantiation325 KB, as well as the List of Health Claims259 KB for more information.

    Advertisements and promotions

    You will require a valid permit from us before publishing any medical advertisements or conducting any sales promotion activities directed to the general public.

    Refer to our advertisements and promotions guidelines for more information on what is required before you run any advertisements and promotions for your products.

    Free Sale Certificate (FSC)

    Some importing countries may require a certificate to show that the product is currently sold and distributed in Singapore.

    As such, local exporters may apply for a FSC from the Health Sciences Authority.

    Each FSC is specific to one product and allows the inclusion of up to five importing countries. Information in the FSC includes:

    1. Name of product
    2. Importing countries
    3. Name and address of the manufacture(s) and distributor(s)
    4. Intended use
    5. Ingredients
    6. Date of Issue of the FSC